Brief: Antisense Therapeutics Says Mark Diamond Advised Of Retirement As CEO
Nov 15 (Reuters) - Antisense Therapeutics Ltd ANP.AX :
* ANTISENSE THERAPEUTICS CEO ANNOUNCES RETIREMENT
* CHIEF EXECUTIVE OFFICER AND MANAGING DIRECTOR, MARK
DIAMOND HAS
ADVISED THAT HE IS RETIRING AS CEO
Source text for Eikon: ID:nASX9xw17B
Further company coverage: ANP.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Percheron Therapeutics
See all newsBrief: Invion Announces Preclinical Research Collaboration With Percheron Therapeutics
Brief: Percheron Therapeutics Receives Firm Commitments For A$2.3 Million Institutional Placement
Brief: Percheron Therapeutics Appoints Ambrosini as Interim Board Member During CEO Transition Period
Brief: Percheron Therapeutics Says Vanderbilt Health To Conduct Clinical Trial Of Hmbd-002 In Acute Myeloid Leukaemia
Brief: Percheron Therapeutics Says James Garner To Step Down As CEO And Managing Director